메뉴 건너뛰기




Volumn 65, Issue 8, 2004, Pages 1144-1145

Respiratory infections rather than antibiotics may increase clozapine levels: A critical review of the literature

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; CLOZAPINE; CYTOCHROME P450 1A2; NEUROLEPTIC AGENT;

EID: 4544247630     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter
Times cited : (32)

References (17)
  • 2
    • 0018190964 scopus 로고
    • Altered theophylline pharmacokinetics during acute respiratory viral illness
    • Chang KC, Bell TD, Lauer BA, et al. Altered theophylline pharmacokinetics during acute respiratory viral illness [letter]. Lancet 1978;1: 1132-1133 (Pubitemid 8356442)
    • (1978) Lancet , vol.1 , Issue.8074 , pp. 1132-1133
    • Chang, K.C.1    Bell, T.D.2    Lauer, B.A.3    Chai, H.4
  • 3
    • 0027462912 scopus 로고
    • Are current pediatric dose recommendations for intravenous theophylline appropriate?
    • Shilalukey K, Robieux I, Spino M, et al. Are current pediatric dose recommendations for intravenous theophylline appropriate? J Asthma 1993;30:109-121
    • (1993) J Asthma , vol.30 , pp. 109-121
    • Shilalukey, K.1    Robieux, I.2    Spino, M.3
  • 4
    • 0018412469 scopus 로고
    • Theophylline pharmacokinetics during respiratory viral infection
    • Clark CJ, Boyd G. Theophylline pharmacokinetics during respiratory viral infections [letter]. Lancet 1979;1:492 (Pubitemid 9127251)
    • (1979) Lancet , vol.1 , Issue.8114 , pp. 492
    • Clark, C.J.1    Boyd, G.2
  • 7
    • 0141851847 scopus 로고    scopus 로고
    • Serious respiratory infections can increase clozapine levels and contribute to side effects: A case report
    • DOI 10.1016/S0278-5846(03)00148-9
    • de Leon J, Diaz FJ. Serious respiratory infections can increase clozapine levels and contribute to side effects: a case report. Prog Neuropsychopharmacol Biol Psychiatry 2003;27:1059-1063 (Pubitemid 37141394)
    • (2003) Progress in Neuro-Psychopharmacology and Biological Psychiatry , vol.27 , Issue.6 , pp. 1059-1063
    • De Leon, J.1    Diaz, F.J.2
  • 10
    • 0028070389 scopus 로고
    • Possible adverse interaction between clozapine and ampicillin in an adolescent with schizophrenia
    • Csik V, Molnar J. Possible adverse interaction between clozapine and ampicillin in an adolescent with schizophrenia. J Child Adolesc Psychopharmacol 1994;4:123-128 (Pubitemid 24253444)
    • (1994) Journal of Child and Adolescent Psychopharmacology , vol.4 , Issue.2 , pp. 123-128
    • Csik, V.1    Molnar, J.2
  • 11
    • 0027440142 scopus 로고
    • Pharmacokinetic drug interactions with antimicrobial agents
    • Gillum JG, Israel DS, Polk RE. Pharmacokinetic drug interactions with antimicrobial agents. Clin Pharmacokinetics 1993;25:450-482 (Pubitemid 23358033)
    • (1993) Clinical Pharmacokinetics , vol.25 , Issue.6 , pp. 450-482
    • Gillum, J.G.1    Israel, D.S.2    Polk, R.E.3
  • 13
    • 0031948562 scopus 로고    scopus 로고
    • Serum concentration of clozapine and N-desmethylclozapine are unaffected by the potent CYP3A4 inhibitor itraconazole
    • Raaska K, Neuvonen PJ. Serum concentration of clozapine and N-desmethylclozapine are unaffected by the potent CYP3A4 inhibitor itraconazole. Eur J Clin Pharmacol 1998;54:167-170
    • (1998) Eur J Clin Pharmacol , vol.54 , pp. 167-170
    • Raaska, K.1    Neuvonen, P.J.2
  • 15
    • 0033667335 scopus 로고    scopus 로고
    • Ciprofloxacin increases serum clozapine and N-desmethylclozapine: A study in patients with schizophrenia
    • Raaska K, Neuvonen PJ. Ciprofloxacin increases serum clozapine and N-desmethylclozapine: a study in patients with schizophrenia. Eur J Clin Pharmacol 2000;56:585-589
    • (2000) Eur J Clin Pharmacol , vol.56 , pp. 585-589
    • Raaska, K.1    Neuvonen, P.J.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.